Xact Laboratories
Xact Laboratories
  • Home
    • XactMed4U™
    • XVIS™
    • XactMed4UTI™
    • XactMed4Women™
    • Payers & Employers
    • PBMs & Pharmacy
    • HIE
    • Healthcare Systems
  • Patient Stories
    • Who We Are
    • Leadership Team
    • News & Events
    • Quality & Compliance
    • Privacy Policy
    • Contact
  • LOGIN
    • Home
    • Products
      • XactMed4U™
      • XVIS™
      • XactMed4UTI™
      • XactMed4Women™
    • Services
      • Payers & Employers
      • PBMs & Pharmacy
      • HIE
      • Healthcare Systems
    • Patient Stories
    • About Us
      • Who We Are
      • Leadership Team
      • News & Events
      • Quality & Compliance
      • Privacy Policy
      • Contact
    • LOGIN
  • Home
  • Patient Stories
  • LOGIN
image170

Evidence Based Prescribing For Optimal Medical Therapy

Evidence Based Prescribing For Optimal Medical TherapyEvidence Based Prescribing For Optimal Medical TherapyEvidence Based Prescribing For Optimal Medical Therapy

Evidence Based Prescribing For Optimal Medical Therapy

Evidence Based Prescribing For Optimal Medical TherapyEvidence Based Prescribing For Optimal Medical TherapyEvidence Based Prescribing For Optimal Medical Therapy

YOUR PARTNER IN PRECISION MEDICINE

 Xact Laboratories is your trusted partner in unlocking the power of precision medicine through technology. We work shoulder-to- shoulder with health care systems, payers, pharmacies, and PBMs to lower costs and ensure that every patient receives personalized medical therapy throughout the health care continuum.

Find out more
image171

Drugs are only therapeutically effective in 20–60% of patients

Drugs are only therapeutically effective in 20–60% of patients

Drugs are only therapeutically effective in 20–60% of patients

Wilkinson GR. Drug metabolism and variability among patients in drug response. N Engl J Med 2005;352(21):2211–2221. 

image172

38–75% of patients show no response to initial treatment

Drugs are only therapeutically effective in 20–60% of patients

Drugs are only therapeutically effective in 20–60% of patients

 Spear BB, Heath-Chiozzi M & Huff J. Clinical application of pharmacogenetics. Trends Mol Med 2001;7(5):201–204. 

image173

ADR affect approximately 2 million hospital stays annually.

Drugs are only therapeutically effective in 20–60% of patients

ADR affect approximately 2 million hospital stays annually.

Baldini A, Von Korff M, Lin EH. A Review of Potential Adverse Effects of Long-Term Opioid Therapy: A Practitioner’s Guide. Prim Care Companion CNS Disord. 2012;14(3).

"Xact leads the way with point of care testing, integration, & clinical decision support"

Find out more

Copyright © 2020 Xact Laboratories - All Rights Reserved.

Cookie Policy

This website uses cookies. By continuing to use this site, you accept our use of cookies.

Accept & Close